CD33 and Alzheimer disease: Numerous genomics studies have suggested that immune function-related AD risk gene loci, such as triggering receptor expressed on myeloid cells 2(TREM2), cluster differentiation 33(CD33), and membrane spanning four domains subfamily A (MS4A), are closely related to the pathogenesis of AD (2, 3).